Cargando…

The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)

OBJECTIVE: The aim of this study was to determine the prevalence of anabolic androgenic steroid (AAS) use among athletes and examine the extent of their knowledge on the effects of AAS in Riyadh, Saudi Arabia. METHODS: This cross-sectional study was conducted at gyms in Riyadh, Saudi Arabia, during...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabari, Mosleh, Al-shehri, Hassan, Al-faris, Abdullah, Al-sayed, Mohammed, Algaeed, Fahd, Al-sobaie, Nasser, Al-saleh, Fawaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Electronic physician 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279964/
https://www.ncbi.nlm.nih.gov/pubmed/28163846
http://dx.doi.org/10.19082/3343
_version_ 1782502871073292288
author Jabari, Mosleh
Al-shehri, Hassan
Al-faris, Abdullah
Al-sayed, Mohammed
Algaeed, Fahd
Al-sobaie, Nasser
Al-saleh, Fawaz
author_facet Jabari, Mosleh
Al-shehri, Hassan
Al-faris, Abdullah
Al-sayed, Mohammed
Algaeed, Fahd
Al-sobaie, Nasser
Al-saleh, Fawaz
author_sort Jabari, Mosleh
collection PubMed
description OBJECTIVE: The aim of this study was to determine the prevalence of anabolic androgenic steroid (AAS) use among athletes and examine the extent of their knowledge on the effects of AAS in Riyadh, Saudi Arabia. METHODS: This cross-sectional study was conducted at gyms in Riyadh, Saudi Arabia, during 2015. In total 600 athletes from three gyms participated in the study. The study included Saudi and non-Saudi athletes chosen by the simple random sampling method. A self-reported questionnaire was used for data collection. The questionnaire was designed to study the prevalence and assess the knowledge of athletes regarding AAS use. Frequency and percentage distributions were used to describe the data. Comparison between the subgroups was made with a chi-square test. RESULTS: The percentage of AAS users was 30.5%. The age of AAS users ranged from 15 to 49 years with the majority (52.5%) belonging to age group of 25–29 years. Approximately 20% of the users admitted using AAS due to body dysmorphia as their best motivational factor; in addition, they also believed that there are no side effects of the use. Among the nonusers, 40% had appropriate knowledge, while all the AAS-users had inadequate knowledge about the adverse effects of AAS. Moreover, 77% of the users would recommend AAS to their friends but none from the nonusers. A significant difference in age distribution (df = 5, p<0.001) and knowledge (df = 4, p< 0.001) between users and nonusers was observed. CONCLUSION: Most athletes were ignorant of the harmful side effects of the drug but still continued to use and promote it to other athletes. These athletes should intensify their knowledge and awareness regarding the use of AAS and its effects on the body.
format Online
Article
Text
id pubmed-5279964
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Electronic physician
record_format MEDLINE/PubMed
spelling pubmed-52799642017-02-03 The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia) Jabari, Mosleh Al-shehri, Hassan Al-faris, Abdullah Al-sayed, Mohammed Algaeed, Fahd Al-sobaie, Nasser Al-saleh, Fawaz Electron Physician Original Article OBJECTIVE: The aim of this study was to determine the prevalence of anabolic androgenic steroid (AAS) use among athletes and examine the extent of their knowledge on the effects of AAS in Riyadh, Saudi Arabia. METHODS: This cross-sectional study was conducted at gyms in Riyadh, Saudi Arabia, during 2015. In total 600 athletes from three gyms participated in the study. The study included Saudi and non-Saudi athletes chosen by the simple random sampling method. A self-reported questionnaire was used for data collection. The questionnaire was designed to study the prevalence and assess the knowledge of athletes regarding AAS use. Frequency and percentage distributions were used to describe the data. Comparison between the subgroups was made with a chi-square test. RESULTS: The percentage of AAS users was 30.5%. The age of AAS users ranged from 15 to 49 years with the majority (52.5%) belonging to age group of 25–29 years. Approximately 20% of the users admitted using AAS due to body dysmorphia as their best motivational factor; in addition, they also believed that there are no side effects of the use. Among the nonusers, 40% had appropriate knowledge, while all the AAS-users had inadequate knowledge about the adverse effects of AAS. Moreover, 77% of the users would recommend AAS to their friends but none from the nonusers. A significant difference in age distribution (df = 5, p<0.001) and knowledge (df = 4, p< 0.001) between users and nonusers was observed. CONCLUSION: Most athletes were ignorant of the harmful side effects of the drug but still continued to use and promote it to other athletes. These athletes should intensify their knowledge and awareness regarding the use of AAS and its effects on the body. Electronic physician 2016-12-25 /pmc/articles/PMC5279964/ /pubmed/28163846 http://dx.doi.org/10.19082/3343 Text en © 2016 The Authors This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Original Article
Jabari, Mosleh
Al-shehri, Hassan
Al-faris, Abdullah
Al-sayed, Mohammed
Algaeed, Fahd
Al-sobaie, Nasser
Al-saleh, Fawaz
The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_full The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_fullStr The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_full_unstemmed The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_short The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia)
title_sort prevalence of anabolic androgenic steroid use amongst athletes in riyadh (saudi arabia)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279964/
https://www.ncbi.nlm.nih.gov/pubmed/28163846
http://dx.doi.org/10.19082/3343
work_keys_str_mv AT jabarimosleh theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alshehrihassan theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alfarisabdullah theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alsayedmohammed theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT algaeedfahd theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alsobaienasser theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alsalehfawaz theprevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT jabarimosleh prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alshehrihassan prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alfarisabdullah prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alsayedmohammed prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT algaeedfahd prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alsobaienasser prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia
AT alsalehfawaz prevalenceofanabolicandrogenicsteroiduseamongstathletesinriyadhsaudiarabia